An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.
View the full Corporate Spotlight
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| RCE | RCE Chart Thread | 09/09/25 | 58 | 14K | |||
|
|||||||
| RCE Biotech | RCE Mechanism for action | 09/09/25 | 18 | 4.8K | |||
|
|||||||
| RCE | Ann: Appendix 4G | 29/08/25 | 0 | 193 | |||
|
|||||||
| RCE | Ann: Annual Report to Shareholders | 29/08/25 | 0 | 249 | |||
|
|||||||
| RCE | Ann: Preliminary Final Report | 29/08/25 | 0 | 259 | |||
|
|||||||
| RCE Biotech | RCE in AFR | 28/08/25 | 2 | 482 | |||
|
|||||||
| RCE | Ann: Notification regarding unquoted securities - RCE | 25/08/25 | 0 | 229 | |||
|
|||||||
| RCE | Ann: Quarterly Activities/Appendix 4C Cash Flow Report | 22/08/25 | 62 | 17K | |||
|
|||||||
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
|
|
|
||||
| View More | |||||
 (20min delay)
|
|||||
|
Last
48.5¢ |
Change
0.005(1.04%) |
Mkt cap ! $131.5M | |||
| Open | High | Low | Value | Volume |
| 49.0¢ | 49.0¢ | 45.5¢ | $51.05K | 106.6K |
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9039 | 46.5¢ |
| Price($) | Vol. | No. |
|---|---|---|
| 48.0¢ | 2959 | 1 |
| Last trade - 11.16am 10/09/2025 (20 minute delay) ? |
|
|||||
|
Last
48.0¢ |
Change
0.005 ( 0.87 %) |
||||
| Open | High | Low | Volume | ||
| 49.0¢ | 49.0¢ | 45.0¢ | 8677 | ||
| Last updated 11.30am 10/09/2025 ? | |||||
| RCE (ASX) Chart |
ASX News
